Gissette Reyes-Soffer. MD FAHA

Congrats to CUIMC NIH T32 scholar Dr. Pavlyha on her first (of many!) AHA presentations! Lp(a) and PVD. #AHA23 . Fantastic to mentor this rising star!

@Lpa_Doc @UCSD @UCSDCardFellows This was a nice historical take...specially for knowing where therapies are going and what may be next. Thank you.

Ok, folks, for those that want to learn about the history of the development of Lp(a) therapies, this is the course for it. It's virtual and very inexpensive. @UCSD @UCSDCardFellows

Publication of Collaborative project: Take home: Lp(a) is associated with Athero-Stroke, mainly ECAD. Its a start, larger cohorts are needed. sciexplor.com/articles/alr.2…

Thanks @family heart foundation#knowLpa for all you do. I like this article? It’s great for public awareness.

Remember to register for the half-day all virtual CME program about Lp(a) hosted by the Penn Lipid Clinic! Great line-up of speakers and live-steamed Q&A. @Lpa_Doc @MWilkinsonMD @DrMichaelShapir @ErinMichos @grsoffer @nationallipid @hillypaige2 @PennCardiology

Lots of science left for our atvb council today! Great first session on platelets and thrombosis! #AHA25 #AHA2025

This was very well done! Great patient cardiologist/endocrinologist and neurologist perspective #AHA2025

#AHA2025 science friends and leaders.

#AHA2025 come join us at 12:30CST@rivergate room! Short talks! Great science!

#AHA2025 Great start to atvb sessions in New Orleans! Incredible engagement. Loving short targeted cross discipline talks!

Join us on Fri, Feb 6, for an all-virtual symposium about Lp(a) hosted by the Penn Lipid Clinic. Great topics and speakers! Register at upenn.cloud-cme.com/lipidmanagemen… @dan_soffer @MarlysLPA @MWilkinsonMD @Lpa_Doc @ErinMichos @MGLevin @grsoffer @DrMichaelShapir

@RajgopalRadhika Thanks for sharing these! Now paper #4 updated guidelines 😂soon?

And #3 from the AHA and ACC👇

The AHA and ACC publish 3 key papers today. Here’s the first👇

#FHAwarenessDay #KnowFH Help the @FamilyHeartFdn raise awareness! @MendedHearts @WomenHeartOrg @HeartNurses @NatForumHDSP @ASPCardio @ABCardio1 @nationallipid @advcardiohealth @KAWilemon @SethJBaumMD @fhpatienteurope @AllisonJamison2 @CMulliganWalsh @hsbhatia

@DrEugeneYang I love Keith ;-)

Great meeting! Thanks for giving me the opportunity to contribute with colleagues and friends!

@AggarwalBrooke @ABC @JAHA_AHA @AHAScience @American_Heart @ColumbiaMed @CUIMCDeptofMed @ColumbiaPS @AHA_Research Congrats on this interview and your work! Gotta get my kids to do this ;-)

Thanks to @ABC News for speaking with me about a new study in @JAHA_AHA showing children and teens who sleep less and use screens more may face higher heart risks: abcnews.go.com/Health/video/k…

@rauldsf_santos Nice to see you @rauldsf_santos keep me posted on paper ❤️

ESC Congress 2025 | Key takeaways from ESC Congress 2025 together with World Congress of Cardiology (2) esc365.escardio.org/?v=S17351-key-…

@doctorvasan @drpablocorral @BNordestgaard All ongoing programs phase 2 data show similar lowering for apo(a) size,

@drpablocorral @grsoffer @BNordestgaard Great work ! I would love to see some papers on the effect of Lp(a) size.

👉Lp(a) and Cardiovascular Disease: unveiling the challenge From epidemiology & pathophysiology (@grsoffer) ➡️ risk management (@BNordestgaard) ➡️ clinical cases (I. Gouni-Berthold) ➡️ emerging therapies (S. Nissen) ➡️ conclusions (J.L. Zamorano). A comprehensive journey through one of the most important frontiers in #CardiovascularPrevention. #Lipoprotein(a) #EASCongress #ASCVD #ESCCongress @society_eas

🚨“1 in 5 people have elevated Lp(a)” “1.5 billion people have elevated Lp(a), which increased the CV risk”🤯 🧬by: Dr Reyes-Soffer 🇺🇸 @grsoffer 🔑 In CV risk stratification, measurement of Lp(a) is key in order to asses and comprehend the patient’s true risk🫀 #SIACenESC

@BowTiedBiotech @drpablocorral @BNordestgaard Hello yes need outcome to treat with Novel therapies, until then decrease all risk and reduce apob (ldl-c) as much as possible to avoid all additional risk. Borge showed the 50mg/dl as high. It’s hard to convert I think he mentioned 105nmol/l(esc updates to guidelines this am)

@drpablocorral @grsoffer @BNordestgaard Do we need Lp(a) outcomes data before treating becomes standard? What is the consensus cutoff above 50 mg/dL (≈125 nmol/L)?

#ESC is soon! Join my colleagues and me as we discuss Lp(a). esc365.escardio.org/ESC-Congress/s…